ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Continued treatment with baricitinib results in meaningful scalp responses among scalp non-responder patients with eyebrow/eyelash regrowth in the first year.

Arash Mostaghimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.